The expression of S100A4 in primary tumor samples was analyzed by Western blot analysis, showing a significantly increased overall expression of S100A4 in tumors lacking AKT3 compared to controls (Fig 6A and 6B). The gene discussed is AKT3; the disease is neoplasm.